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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S275surgical attempts, autologous chondrocyte implantation (ACI) was the ﬁrst
cell therapy approach developed for these kinds of lesions. Chondrocyte
usage nevertheless is limited by the dedifferentiation occurred when
expanded in monolayer. Bone marrow-derived Mesenchymal Stem Cells
(MSC) emerge as ideal cells to be implanted in the site of cartilage lesions.
Methods: Here we use MSC to treat sheep cartilage lesions implanted in
the upper cartilage layer of bilayered PLLA scaffolds, which hold a lower
layer enriched with Hydroxiapatite to facilitate osteointegration of the
scaffold.
Results: After evolutions of 1.5, 3 and 6 months, lesions showed a slight
but non signiﬁcant decrease in the mankin score for cartilage found in the
lesioned area (in animals treated with unloaded and cell loaded scaffolds)
suggesting a progressive degradation of the tissue. Nevertheless, staining
with Safranine-O showed the presence of more cartilaginous tissue in
animals evolve for 6 months with MSC loaded scaffolds, demonstrating
a more regeneration of the tissue when MSC were implanted in cartilage
lesions. Unfortunately new formed tissue did not appear in the cartilage
layer, but inside the hole performed during surgery, which might suggest
some incapacity of the scaffold to support the presence of cells aligned
with the surface in order to integrate tissue to the surrounding cartilage.
Finally, collagen type II and aggrecanwere found in the regenerated tissue.
Conclusions: The use of MSCs is a promising alternative for the treatment
of cartilage damage, but administration in the core of scaffolds needs to be
improved.
546
MESENCHYMAL STEM CELL THERAPY IN A RAT MODEL OF
OSTEOARTHRITIS
G.M. van Buul 1, M. Siebelt 1, M.J. Leijs 1, P. Bos 1, J.H. Waarsing 1, N. Kops 1,
H. Weinans 1,2, J.A. Verhaar 1, M.R. Bernsen 1, G.J. van Osch 1. 1 Erasmus MC,
Rotterdam, Netherlands; 2Delft Univ. of Technology, Delft, Netherlands
Purpose: Mesenchymal stem cells (MSCs) are promising candidates for
cartilage regeneration and osteoarthritis (OA) therapies, due to their ability
to form cartilage and to secrete immunomodulatory factors. Since OA
comprises many different processes, we evaluated the effects of intra-
articularly injected cultured MSCs on multiple aspects of OA pathology,
including pain, cartilage degeneration and subchondral bone changes, in
a rat model in vivo. In order to explore potential options to enhance clinical
translatability, we studied rat- and human cultured MSCs, as well as
freshly isolated rat bone marrow mononuclear cells (BMMNCs).
Methods: Osteoarthritis was induced unilaterally in 32 male wistar rats
(16 weeks old) by intra-articular injection with 300 mg mono-iodoacetate
(MIA). Three weeks after OA induction rats were randomly divided into
four treatment groups: 1. Control (saline); 2. Rat MSCs; 3. Rat BMMNCs and
4. HumanMSCs. Rat MSCs and humanMSCs were given at a dose of 1 x 106
cells in 50ul saline per joint, rat BMMNCs were given at a dose of 10 x 106.
Rats where euthanized four weeks after treatment injections. Before and
after OA induction, as well as 4 weeks after treatment, hind limb weight
distribution between the osteoarthritic and the contralateral healthy joint
was used as an index of joint discomfort. Ex vivo uCT analysis was per-
fomed to assess changes in the subchondral bone plate and histology was
used to evaluate loss of glycosaminoglycans and development of structural
damage in the cartilage at the endpoint of the study. Statistical analysis
was performed with repeated measures ANOVA and paired t-tests for hind
limb weight distribution, with one way ANOVA and unpaired t-tests for
mCT data, and with non-parametric Kruskal-Wallis and Mann-Whitney-
tests for histology scores. For all tests, p values <0.05 were considered
statistically signiﬁcant.
Results: Hind limb weight distribution (Figure 1): After MIA injection,
signiﬁcantly less weight was distributed to the affected leg compared to
baseline (P < 0.001), indicating pain sensation. The rats treated with rat
MSCs distributed signiﬁcantly more weight to their affected paw 4 weeks
after treatment than before treatment (P ¼ 0.003), whereas none of the
other groups showed a signiﬁcant change in weight distribution. The
groups however, did not differ statistically signiﬁcant at the endpoint of
the study.
Subchondral bone changes: MIA injected knees had a signiﬁcantly more
porous (P < 0.001) and thinner (P ¼ 0.005) subchondral plate than controlknees. Rats treated with rat MSCs or rat BMMNCs showed the least sub-
chondral bone changes, although no statistically signiﬁcant differences
between treatment groups were observed.
Cartilage quality: Knees injected with MIA had lost GAG and developed
structural damage (P< 0.001 for both compared to control knees). Median
GAG loss and structural damage was less in the group treated with rat
MSCs than in the saline treated group, albeit no signiﬁcant differences
were found between any of the treatment groups.
Conclusions: The treatment with injection of rat MSCs caused a signiﬁcant
increase in weight distributed to the affected limb, indicating a reduction
of joint discomfort. This is the ﬁrst study that evaluates the effect of cell
therapy on pain in a small animal OAmodel. In addition, the injection of rat
MSCs caused a trend towards reduction of cartilage and subchondral bone
changes, albeit no signiﬁcant differences were observed between any of
the treatment groups. The absence of statistically signiﬁcant effects of the
treatments on cartilage and bone structure might be related to several
factors, including the time of injection, the OA model or the number of
injected cells. To improve treatment effect, cell number, cell type and the
time point of treatment should be further optimized.
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CARTILAGE- AND SUBCHONDRAL BONE DERIVED FACTORS REGULATE
COLLAGEN PRODUCTION IN MSC
M. Leyh 1, A. Bruckmann 1, W. Richter 2, J. Beckmann 1, J. Grifka 1,
S. Grässel 1. 1Univ. Regensburg, Regensburg, Germany; 2Univ. Hosp.
Heidelberg, Heidelberg, Germany
Purpose: Functional repair of critical size articular cartilage defects is still
a considerable challenge in the ﬁeld of tissue regeneration. To effectively
improve the quality and durability of tissue-engineered neocartilage
a better understanding of microenvironmental cues provided from
surrounding cartilage and subchondral bone tissue and the modulating
inﬂuence of neighbouring cells and tissue interfaces in vivo on chondro-
genic differentiation of MSC are essential.
This study is designed to identify microenvironmental conditions which
promote, prevent or interfere with chondrogenic differentiation of
mesenchymal stem cells (MSC) and to analyse their impact on hyaline
cartilage like quality and biomechanical properties of regenerated tissue.
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(1:1) were embedded in a 3D-ﬁbringel and either kept in monoculture or
were cocultured with cartilage or subchondral bone explants (obtained
from arthroplastic surgery due to OA) for up to 28 days. Matrix production
and chondrogenic characteristics of cells were determined immunohis-
tologically (collagens I, II and III) and histologically (aggrecan) after 7,14, 21
and 28 days. Gene expression of SOX9, COL1A1, COL2A1, COL3A1 and
COL10A1 and of two miRNAs was analyzed after 7 and 28 days with
quantitative real-time PCR. Protein expression in the cell-ﬁbrin constructs
was assessed with ELISA (collagen I / II), western blot (Sox9, phospho-Sox9
and collagen III) and glycosaminoglycan (GAGs) production was analyzed
using a DMMB-assay. The culture supernatant was analyzed for collagen
fragments by a hydroxyproline assay and for PTHrP with an ELISA. We
separated the supernatants from MSC - monocultures versus cartilage
cocultures with SDS-PAGE and identiﬁed differentially secreted proteins
with MALDI-TOF.
Results: MSC underwent chondrogenic differentiation with respect to
collagen II expression in all culture conditions. In comparison to mono-
cultures, collagen I, II and III gene expression and protein production was
suppressed when MSC or chondrocytes were cocultured with cartilage or
subchondral bone explants. Mixed cultures of chondrocytes and MSC
showed a reduced collagen II production in all culture regimes. GAG
production and total collagen content in the supernatant was altered in
bone explant cocultures only. Phospho-Sox9 and PTHrP protein expression
were not signiﬁcantly affected by any culture condition. However,
preliminary data indicate a correlation between miRNA expression and
regulation of sox9 protein. MALDI-TOF analysis revealed several proteins/
factors present in coculture supernatants but not in the monocultured
controls (e.g. stromelysin-1, chondroadherin, ﬁbronectin and SPARC).
Conclusions: Chondrogenic differentiation of MSC is affected by the
microenvironmental conditions. Cartilage and subchondral bone explants
from OA-patients suppress collagen I, II and III gene expression and
production in MSC. This observation might be partly dependent on regu-
lation of sox9 protein biosynthesis by miRNA. Future studies with ovine
tissue will delineate if healthy cartilage/subchondral bone provokes
different responses in MSC compared to OA derived tissues.
Chondroadherin, ﬁbronectin, SPARC and stromelysin-1 among other, yet
unidentiﬁed proteins, were detected in coculture supernatants and might
be associated with the reduced collagen content in OA-cartilage/sub-
chondral bone cocultures of MSC. We will study a putative link between
these factors and regulation of collagen expression and degradation in
further analyses.
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T3 EFFECT THROUGH SCR2 ON CHONDROGENESIS IN VITRO
M.C. Arufe 1,2, A. De la Fuente 2, P. Fernández-Pernas 1, I. Fuentes-
Boquete 2, F. De Toro 2, F.J. Blanco 1,2. 1Dept. of Med.. Faculty of Hlth.Sci..
INIBIC-CHUAC, A Coruña, Spain; 2Osteoarticular and Aging Res. Lab..
INIBIC-CHUAC, A Coruña, Spain
Purpose: There are evidences about the thyroid hormone role into chon-
drogenesis but its molecular implication is not clear. The current study
treats to answer this question working about a new in vitro model of
chondrogenesis using mesenchymal stem cells (MSCs) from human
umbilical cord stroma tissues
Methods: The umbilical cord tissues were obtained from caesareans from
healthy women in the Maternity Facility at Complejo Hospitalario Uni-
versitario de A Coruña under the supervision of the hospital ethic
committee. MSCs were isolated from umbilical cord stroma tissue using an
enzymatic digestion and cultured the cells adhered to the plastic plate.
Chondrogenic process was performed using our model which consisted in
growing the cells during two days in mediumwith FCS 10% in DMEM. After
2 days the mediumwas replaced by a mediumwith KO serum and TGF-ß3
which induces the chondrogenesis. Different amounts of human T3 (1, 10
or 100 ng/mL) were adding to the medium to test their role into chon-
drogenesis process, also different experiments with T3 alone or together
with M151, a speciﬁc steroid covalent receptor type 2 (SCR2) inhibitor, in
the chondrogenic medium, were performance to check which was the T3
receptor which had a active role in the chondrogenesis. Spheroids made bythis method were collected after 7, 14 and 28 days in culture and storage at
-20oC for their posterior analysis. Immunohistochemistry analysis of
spheroids against COL2, COL1 and aggrecane stain was performed to check
chondrogenic differentiation stage and quantitative RT-PCR to check
expression of COL2, COL1 and SOX9 genes also was made. Furthermore,
proteins involved into Wnt (Beta-catenin and GSK3-B) and Notch (Notch2
and Jagged) pathways were analyzed by western.
Results: Immunohistochemistry analysis of the tissues from the spheroids
demonstrated that 100 ng/mL of T3 improved signiﬁcantly (P<0.05) the
COL2andaggrecane staining after 14 days into chondrogenicmediumversus
chondrogenic medium without T3. This improving was totally withdrawal
when the SCR2 inhibitor, M151, was added to themedium at 2.5 ng/mL dose.
Quantitative RT-PCR analysis conﬁrm the immunohistochemistry results,
improving signiﬁcantly (P<0.05) the COL2 and aggrecane gene expression
after 14 days into chondrogenic mediumwhen 100 ng/mL of T3was present
and revealed that expression of COL1 was signiﬁcantly increased (P<0.05)
when M151 (2.5 ng/mL) was added to this medium. Western analysis indi-
cated that Beta-cateninwas increased in the spheroidswhenT3 (100 ng/mL)
was in the medium after 14 days (2 fold) with respect to medium alone and
was decreased until basal levels found in spheroids growth into medium
without T3, whenM151 (2.5 ng/mL)was present in themedium.Notch2 and
Jagged was decreased (2 fold) during the chondrogenesis when T3 was
present in themediumwith respect tomediumalone and the opposite effect
was found when M151 was present in the medium.
Conclusions: T3 is improving the chondrogenic differentiation of
mesenchymal stem cells from umbilical cord tissue. That effect was made
through SCR2 as well as T3 is associated the expression of B-catenin and
Notch2 in our chondrogenic model.
549
INTRA-ARTICULAR INJECTION OF ADIPOSE-DERIVED STEM CELLS
PREVENTS CARTILAGE DESTRUCTION, NEW BONE FORMATION IN THE
LIGAMENTS AND LOWERS SYNOVIAL ACTIVATION
M.C. ter Huurne 1, P.L. van Lent 1, A.B. Blom 1, R. Blattes 2, L. Casteilla 2,
C. Jorgensen 3, W.B. van den Berg 1. 1Radboud Univ. Nijmegen Med. Ctr.,
Nijmegen, Netherlands; 2 STROMALab UPS/CNRS UMR5273, EFS, INSERM
U1031, Toulouse, France; 3 Inserm, Montpellier, France
Purpose: Synovial activation is evident in a substantial subpopulation of
patients with early osteoarthritis (OA) and has been associated with
pathophysiology and clinical symptoms of OA. Previous studies have
shown that activated synovial macrophages are involved in mediating
cartilage destruction as well as the formation of osteophytes during
experimental OA. Recently it has been shown that Adipose-derived
Stroma/Stem Cells (ASCs) express immunosuppressive characteristics. The
aim of our study was to explore the effect of an intra-articular injection of
ASCs on joint pathology during experimental OA.
Methods: ASCs were isolated from inguinal fat surrounding the popliteal
lymph nodes and cultured for two weeks according to standard proce-
dures. ASC were characterized with FACS analysis on a set of speciﬁc cell
surface markers. Experimental OAwas induced by injection of collagenase
into murine knee joints, which causes instability and cartilage destruction.
Collagenase-induced OA is characterized by thickening and activation of
the synovial lining layer. ASCs were injected into knee joints at various
time-points after induction of OA. OA phenotypes were measured within 8
weeks after induction. Total knee joints were isolated and processed for
histology. Synovial activation was measured using an arbitrary scale (0 to
3) and cartilage destruction was measured in 4 different layers of the knee
joint (medial and lateral tibia and femur) according to the scoring method
of Pritzker et al. 2006. Moreover, newly formed bone in the ligaments was
quantiﬁed using image analyses.
Results: After culture FACS analysis showed that the adherent fraction
expressed characteristic markers for stem cells (positive staining for Sca-1,
CD-44 and CD-105 and negative staining for CD-11b and cKIT). A single
dose of ASCs (20x103 in mouse serum) was injected into the knee joint of
mice, 7 days after induction of osteoarthritis. Synovial activation was
inhibited at day 14 (9%) and day 42 (31%) (P< 0.05) after treatment when
compared to serum injected knee joints. Destruction of cartilage was also
inhibited at day 14 and signiﬁcantly at day 42 (35%). Inhibition of cartilage
